featured
Pembrolizumab for Patients With PD-L1-Positive Advanced Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab for Patients With PD-L1-Positive Advanced Gastric Cancer (KEYNOTE-012): A Multicentre, Open-Label, Phase 1b Trial
Lancet Oncol 2016 May 03;[EPub Ahead of Print], K Muro, HC Chung, V Shankaran, R Geva, D Catenacci, S Gupta, JP Eder, T Golan, DT Le, B Burtness, AJ McRee, CC Lin, K Pathiraja, J Lunceford, K Emancipator, J Juco, M Koshiji, YJ BangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.